WHO ICTRP trial
comparison of sequential-concomitant hybrid to sequential therapy in h.pylori…
IRCT201110312499N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201110312499N2 |
|---|---|
| Public title | comparison of sequential-concomitant hybrid to sequential therapy in h.pylori eradication rate |
| Scientific title | hybrid therapy in H.pylori |
| Primary sponsor | Vice Chancellor For Research, Mazandaran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | PUD(H.PYLORI ERADICATION REGIMEN). GASTRIC ULCER,DUODENAL ULCER,PEPTIC ULCER DISEASE, GASRTRODUODENITIS;K25.9,K26.;GASTRIC ULCER,DUODENAL ULCER,PEPTIC ULCER DISEASE, GASRTRODUODENITIS |
| Interventions | Intervention 1: Intervention group: pantoprazole 40mg (BD) + Amoxicillin 1g (BD) + Clarithromycin 500mg (BD) and Tinidazole 500mg (BD) during the first 2 weeks. Intervention 2: Control group: pantoprazole 40mg (BD) for 10 days + Amoxicillin… |
| Registration date | Dec 2, 2011 |
| Target size | 296 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: